title: Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis.
authors: Department of Cardiology, Westmead Hospital, Sydney, Australia. Electronic address: kphan.vc@gmail.com.
authors: Kevin
authors: K
authors: Phan
authors: University of Sydney, Sydney, Australia.
authors: Nelson
authors: N
authors: Wang
authors: Department of Cardiology, Maastricht University Hospital, Maastricht, The Netherlands.
authors: Laurent
authors: L
authors: Pison
authors: Department of Cardiology, Maastricht University Hospital, Maastricht, The Netherlands.
authors: Narendra
authors: N
authors: Kumar
authors: Department of Surgery, Westmead Hospital, Sydney, Australia.
authors: Kerry
authors: K
authors: Hitos
authors: Department of Cardiology, Westmead Hospital, Sydney, Australia.
authors: Stuart P
authors: SP
authors: Thomas
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000601:surgery*; D017115:Catheter Ablation; D000069604:Dabigatran / Q000627:therapeutic use*; D065427:Factor Xa Inhibitors / Q000627:therapeutic use; D006801:Humans; D015201:Meta-Analysis as Topic; D000069552:Rivaroxaban / Q000627:therapeutic use*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D065427:Factor Xa Inhibitors; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran
keywords: Ablation; Dabigatran; Rivaroxaban; Thromboembolism; VKA; Warfarin